Clinical Trial Update: Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating expanded natural killer (NK) cell immunotherapy for relapsed or refractory neuroblastoma, sponsored by the New Approaches to Neuroblast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Expanded NK cell immunotherapy (expanded natural killer (NK) cells)

Snippet

Sponsor: New Approaches to Neuroblastoma Therapy Consortium | Conditions: Neuroblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING